Medicine & Pharmaceuticals News
RPT Labs Sets New Standards for Accuracy Among Drug Testing Labs in Billerica
RPT Labs has raised the bar for precision and reliability among drug testing labs in Billerica , offering an approach that combines meticulous procedures with practical insights tailored to a diverse client base. Situated just outside Billerica, RPT Labs operates from its Lowell location, providing accessible, trusted screening services that emphasize accuracy, compliance, and clear communication. With a focus on stringent chain-of-custody protocols and advanced technology, the organization serves employers, legal professionals, and individuals who require dependable results with a transparent process. Every stage of the screening journey at RPT Labs is designed to minimize errors and maintain sample integrity. From initial collection to final reporting, trained staff follow standardized methods that safeguard against contamination or tampering. Clear documentation and digital tracking systems ensure an unbroken chain of custody, a critical factor for results that stand up in court or regulatory reviews. Clients can expect a streamlined experience where each step—from appointment setting to receiving results—is handled efficiently without sacrificing thoroughness. One of the defining features of RPT Labs is its commitment to clear, straightforward communication. Turnaround times are outlined upfront, helping organizations and individuals plan accordingly. While rapid screenings can deliver same-day outcomes suitable for urgent needs, confirmatory processes generally take between 24 and 72 hours to ensure accuracy. This balance allows clients to make informed decisions based on reliable information rather than rushed or inconclusive data. In the middle of the service offerings, RPT Labs distinguishes itself among drug testing labs in Billerica by integrating customized programs and ongoing consultation. Understanding that workplace requirements and regulatory environments vary, RPT Labs helps craft policies aligned with Massachusetts regulations. This includes guidance on drug-free workplace initiatives that reflect the unique needs of each business, whether small-scale operations or larger enterprises along the Route 128 corridor. The emphasis on data-driven recommendations ensures these programs remain compliant and effective over time. The range of testing methods available accommodates various screening objectives. From saliva and hair analysis to blood collections, the options are tailored to detect specific substances or fulfill legal and workplace criteria. Training for collection personnel adheres to strict standards, maintaining consistency and professionalism across all procedures. This expertise extends to specialized services such as mobile collection units, which bring testing directly to job sites or events, reducing disruption and improving participation rates. Confidentiality is a cornerstone of the lab’s operations. All results are handled with the utmost discretion and shared only with authorized parties under secure conditions that meet federal privacy guidelines. This commitment reassures clients that sensitive information remains protected throughout the process, supporting both legal compliance and individual privacy concerns. RPT Labs maintains rigorous internal quality control measures that include proficiency testing, equipment calibration, and method validation. These protocols ensure that every test meets or exceeds regulatory expectations, whether for Department of Transportation compliance or court-admissible evidence. Medical Review Officers review all non-negative results, carefully considering legitimate prescriptions or medical explanations to avoid false positives. This layered approach reinforces the credibility and defensibility of each report. Beyond testing accuracy, RPT Labs understands the importance of education and support. Employers and organizations benefit from training programs focused on reasonable suspicion recognition and regulatory compliance, empowering supervisors to identify potential issues confidently. Additionally, expert guidance is available to interpret results and provide next-step resources, including connections to treatment referrals or employee assistance programs when necessary. The integration of modern technology enhances the lab’s capability to deliver timely, reliable outcomes. Laboratory Information Management Systems (LIMS) streamline sample tracking and reporting, improving transparency and reducing manual errors. Artificial intelligence and data analytics support quality control by detecting anomalies or potential adulteration, further securing the integrity of results. Clients seeking testing services in the greater Billerica area will find that RPT Labs offers a comprehensive, trustworthy option that combines technical precision with practical, client-focused service. Whether addressing pre-employment screening, ongoing compliance, or legal requirements, the lab’s consistent emphasis on accuracy and clear communication provides a solid foundation for decision-making. For businesses, legal professionals, or individuals looking to begin the process, RPT Labs offers accessible appointment options and mobile services tailored to specific needs. Transparency around costs, timelines, and procedural details ensures no surprises along the way, fostering confidence in every test administered. With a commitment to excellence and continuous improvement, RPT Labs stands ready to support clients throughout Massachusetts in maintaining safe, compliant environments supported by dependable results. Scheduling a consultation or exploring testing services can be done through secure online portals or direct phone contact, allowing clients to take the next step with clarity and assurance. Whether initiating a new program or managing ongoing compliance, RPT Labs provides the expertise and resources needed to navigate complex screening requirements with ease. About RPT Labs: RPT Labs is your trusted source for comprehensive Drug and DNA testing solutions. Based in Massachusetts, we are proud to serve clients across the state and beyond with a steadfast commitment to excellence. At RPT Labs, we embody the values of customer service, integrity, knowledge, and a passion for the industry, ensuring that you receive the highest quality testing services tailored to your needs.
Mom’s Genes Influence Child’s ADHD Risk – Even Without Passing on DNA, Study Finds
Sane.Medical Redefines Individual Health and Well-being Through Personalized Care
SANE. Medical Brings Personalized Wellness and Hormone Therapy to Navarre
- August 16, 2025Medicine & Pharmaceuticals
SANE.Medical Prioritizes Lasting Solutions in Personalized Weight Management
SANE.Medical is reaffirming its commitment to high-performing individuals who feel unwell despite their best efforts—those battling fatigue, weight gain, bloating, or brain fog while being told it’s “just aging” or “normal.” Through customized weight management programs, SANE.Medical provides targeted, thoughtful care tailored to the realities of those who feel overlooked by conventional approaches. Unlike standardized care models, SANE.Medical operates on the principle that healing requires addressing more than symptoms. Root cause testing, hormone balance strategies, and therapies to restore energy and clarity are core to the practice’s personalized approach to holistic care in Navarre, FL . "Many of my patients arrive exhausted, frustrated, and told that nothing is wrong—despite knowing deep down that something is off," said a spokesperson for SANE.Medical. “They’ve tried everything, and they’re still stuck. We work together to uncover the why, not just manage the what.” SANE.Medical’s individualized weight loss programs are designed to confront the layered challenges of obesity, which remains a complex, chronic medical issue for millions. Instead of reducing care to a number on the scale, the practice considers emotional well-being, metabolic health, hormone function, and lifestyle dynamics as part of its treatment path. “Obesity isn’t just about overeating or poor discipline—it’s a multifactorial condition that requires empathy and clinical insight,” the spokesperson added. “That’s why our plans are tailored. We don’t apply formulas; we listen.” The practice provides holistic care in Navarre, FL, that reflects the needs of individuals who feel burned out or misdiagnosed. For many, it's the first time they've been seen as a whole person—not a collection of symptoms. Whether addressing stubborn weight gain, persistent energy crashes, or issues like dull skin or brain fog, SANE.Medical care strategies are crafted with long-term well-being in mind. Every aspect of the program is intentional and personalized—designed not only to initiate change, but to sustain it. SANE.Medical continues to serve individuals who are ready for something more—more clarity, more energy, more balance. It remains a dedicated partner in helping clients reclaim health and self-trust through evidence-based, individualized care.
- August 15, 2025Medicine & Pharmaceuticals
Filmmaker Chris Dela Cruz Brings Global Crisis to Light with 'Tiny Hearts' Premiere
Filmmaker Chris Dela Cruz has announced the world premiere of Tiny Hearts , a feature-length documentary chronicling pediatric heart surgeon Dr. William Novick and the Global Cardiac Alliance as they respond to urgent medical needs in conflict-affected countries. Filmed over five years in seven nations—including Lebanon, Iraq, Ukraine, and the Democratic Republic of Congo—the documentary provides direct access to life-saving surgeries for children born with congenital heart defects in regions facing war, instability, and resource scarcity. Photo Courtesy of: Chris Robbins/Jordan Campbell The film captures front-line medical missions as Novick’s team confronts challenging conditions, frequent shortages, and unrelenting chaos. “We go where the need is,” Dr. Novick said. “That’s the only compass that matters.” Tiny Hearts forgoes dramatization to show the realities of surgery in overstretched hospitals, highlighting the logistics, teamwork, and determination required for each operation. Dela Cruz, who is a Writers Guild of America member and former video editor, also contributed financially, along with other financial contributors. He gained unprecedented access to the stories unfolding inside war zone hospitals. “I didn’t want to just observe—I wanted to immerse myself,” said Dela Cruz. “That meant being in the ICU, breathing the same air, feeling the urgency of every heartbeat. The emotional weight of it. The moral gravity.” He added, “This isn’t just a documentary. It’s a call to action. These children are real. Their stories matter. And if this film helps save even one more life, then everything I gave up was worth it.” The documentary also features original music by Grammy Award-winning producer Philip Lawrence, with additional contributions from Christina Perri and a score by Edmund Butt and Benjamin Wallfisch. Michael Lehmann Boddicker oversaw audio post-production. Tiny Hearts is scheduled for premiere at major film festivals in 2025. About Tiny Hearts Tiny Hearts is a feature-length documentary directed by Chris Dela Cruz that brings audiences into the challenging world of pediatric heart surgery in conflict and crisis regions. Filmed over five years in seven countries—including Lebanon, Iraq, Ukraine, and the Democratic Republic of Congo—the film documents the work of Dr. William Novick and the Global Cardiac Alliance as they perform surgeries for children with congenital heart defects. With unprecedented access to medical teams, patients, and families, Tiny Hearts provides a clear look at the realities faced in resource-limited hospitals and the impact of humanitarian intervention. The film’s original score and contributions from award-winning musicians further enhance its powerful storytelling. Tiny Hearts aims to raise global awareness about pediatric healthcare inequalities in war-torn areas.
- August 12, 2025Medicine & Pharmaceuticals
AI Medical Platform Roboclinic Dramatically Boosts Patient Consultations as Global Healthcare Embraces the Digital Age
Roboclinic , an AI-powered medical consultation platform, has reached a significant milestone of over 1 million AI-led medical sessions across web and mobile platforms, demonstrating the growing acceptance of artificial intelligence in healthcare delivery. The platform, which combines advanced AI technology with clinical expertise, has achieved 97 percent diagnostic accuracy in internal testing, significantly outperforming traditional healthcare benchmarks. Photo Courtesy of Vlad Muradkhanov The achievement comes as the global AI in medicine market experiences significant growth, with projections indicating expansion from $20.9 billion in 2024 to over $164.12 billion by 2030. Roboclinic's success reflects broader industry trends showing AI systems enhancing decision-making accuracy in healthcare by over 30% in 2024. An Approach to Healthcare Access that is Gaining Momentum Roboclinic operates as an AI medical chat that interacts with users like a real doctor, asking questions, analyzing symptoms, and providing likely diagnoses, treatment plans, and test recommendations. The platform allows users to upload photos of medical conditions, such as skin rashes or eye issues, and receive instant, structured medical-grade insights backed by authoritative medical sources. " One of the biggest barriers in healthcare is the hesitation to seek help. Many patients are unsure whether their condition warrants medical attention and wait until symptoms become severe ," says Vlad Muradkhanov , founder of Roboclinic, " Roboclinic removes that barrier by providing instant, private AI medical guidance that helps users understand what's happening and what kind of care they might need ." The platform's clinical approach distinguishes it from other AI health tools. All flows, questions, and decisions are based on medical guidelines and diagnostic reasoning specifically designed for AI applications. At its core, Roboclinic utilizes a custom-built system that combines large language models with a clinical knowledge base crafted by physicians, including clinical guidelines, diagnostic logic, and treatment pathways. Strong Market Performance and User Adoption Since launch, Roboclinic has attracted over 500,000 users globally, with particularly strong early adoption in Latin America and Southeast Asia. The platform's usage patterns reveal significant demand across multiple medical specialties, with dermatology representing approximately 30% of all consultations, gynecological and women's health topics accounting for 20% of sessions, and general internal medicine comprising 15% of inquiries. The platform offers flexible payment options, including a 20-question bundle, a monthly subscription, and a yearly subscription. Most users begin with the question bundle before transitioning to subscription models as they become more familiar with AI-based health tools. " In internal validation, Roboclinic has reached 97 percent diagnostic accuracy, significantly outperforming traditional benchmarks. For comparison, studies show the average diagnostic accuracy of physicians in routine clinical practice is around 74 percent ," noted Muradkhanov, referencing Stanford HAI research from 2024. Strategic Partnerships and Global Expansion Roboclinic has secured partnership agreements with clinical networks in Latin America and Europe, enabling the platform to offer full-cycle care, including validation by licensed doctors, prescriptions, referrals, and official treatment plans directly within the platform. Over the next 12 months, the company plans to expand this model to the Middle East and Southeast Asia through similar partnerships with regional medical networks. The platform has also launched a native iOS application, making healthcare guidance more accessible to mobile users. This expansion aligns with broader industry trends showing AI applications in healthcare becoming increasingly sophisticated, with robot-assisted surgery valued at $40 billion and virtual nursing assistants projected to reach $20 billion by 2026. Extensive Experience in Healthcare Brought to Bear The founding team brings over 15 years of healthcare experience to Roboclinic. Founder Vlad Muradkhanov brings extensive healthtech entrepreneurship and operations experience to the company, while co-founder Anna Grigorieva is a licensed medical doctor specializing in dermatology, oncology, and radiology, who previously served as medical director of the acquired nuclear medicine company. " We see a future where AI clinics will become the cloud-based entry point to healthcare, routing patients directly to diagnostics or treatment. People will talk to AI first, get clear direction, and only go further when necessary ," said Muradkhanov, " as regulators begin to trust AI with primary medical decisions, clinicians will shift into oversight and procedural roles, and the barriers to care will finally come down ." Visit the Roboclinic website to learn more about AI-powered medical consultations. About Roboclinic Roboclinic is an AI-powered medical consultation platform that provides instant, structured medical guidance through advanced artificial intelligence technology. The platform combines large language models with clinical knowledge bases developed by physicians to deliver medical-grade insights backed by authoritative sources. Roboclinic serves over 500,000 users globally and has achieved 97% diagnostic accuracy in internal testing. The company maintains partnerships with clinical networks across Latin America and Europe to provide comprehensive healthcare solutions.
- August 9, 2025Medicine & Pharmaceuticals
CAPSERO AG Wins Best Digital Agriculture Platform in Switzerland for 2025
CAPSERO AG Pioneers a New Era in Plant-Based Raw Material and Ingredient Production The demand for plant-based active ingredients in pharmaceuticals, cosmetics, and nutraceuticals is growing rapidly. However, the regulatory landscape surrounding their production is becoming stricter. Frameworks like GACP, GMP, and ISO 22716 are now industry standards, pushing traditional open-field cultivation methods under increased scrutiny. Open-field farming is no longer sustainable or compliant enough for industries relying on botanicals for their products. CAPSERO AG, a Swiss AgTech company, has introduced a revolutionary solution to address this challenge. The company’s fully automated, sterile in-vitro production platform provides scalable, sustainable, and regulatory-compliant production of plant-based raw materials for the pharmaceutical, cosmetic, and nutraceutical industries. It offers a cleaner, more efficient alternative to outdoor cultivation, resolving both regulatory and environmental concerns. Overcoming the Challenges of Open-Field Cultivation Plants such as Aloe Vera, Curcuma, and Artemisia annua are widely used in the pharmaceutical and cosmetic industries. However, the rising regulatory requirements make it harder to rely on open-field cultivation. Outdoor farming exposes crops to unpredictable weather, pests, and other external variables, leading to inconsistent quality. This variability poses significant risks to production schedules, product quality, and compliance for industries that demand precise, standardized raw materials. CAPSERO offers a solution that ensures consistency, reproducibility, and high-quality plant material, fully compliant with global regulatory standards. Their platform guarantees a reliable, controlled alternative to traditional farming methods. CAPSERO’s In-Vitro Platform: A Game-Changer for Plant-Based Ingredient Production CAPSERO’s in-vitro cultivation system combines a patented capsule technology with modular cultivation units, creating a fully automated platform for plant production. Designed to meet the highest standards of GMP, GACP, and ISO 22716, the system ensures every batch of raw material meets rigorous quality benchmarks. The platform is modular and scalable, allowing companies to deploy production units near processing facilities or in areas where open-field farming is not viable. With the integration of artificial intelligence (AI), CAPSERO optimizes plant growth and yield in real-time. Additionally, each plant batch is digitally tracked from DNA to the end product, ensuring full traceability and regulatory compliance. “We are not just growing plants; we are creating a digital twin of each batch, optimizing growth, yield, and quality,” says Fabio Cirillo, CEO of CAPSERO. “This allows us to ensure consistency and quality at scale while enhancing efficiency and sustainability.” Environmental Benefits and Sustainability CAPSERO’s technology offers substantial environmental benefits. Traditional open-field farming requires extensive water, arable land, and pesticides, but CAPSERO’s closed-loop system reduces water usage by up to 30% and eliminates the need for pesticides. The platform’s efficiency leads to a 62% reduction in CO₂ emissions, offering a far more sustainable approach to producing plant-based ingredients. Moreover, CAPSERO alleviates the pressure on ecosystems and biodiversity often caused by agricultural expansion. By using minimal land and resources, the company provides an eco-friendly alternative to plant cultivation, contributing positively to the fight against climate change. Precision, AI Optimization, and Regulatory Compliance More than just automation, CAPSERO’s platform brings unprecedented precision to plant cultivation. Through AI-driven growth optimization, the system continuously improves cultivation protocols. AI models utilize data from every batch to refine conditions necessary for optimal growth, yield, and metabolite production. This ability to predict growth patterns and optimize cultivation parameters allows CAPSERO to help companies meet the increasing regulatory demands without compromising on quality or efficiency. The platform also enables rapid scaling of production, providing reliable raw material sources for companies, all while ensuring full regulatory compliance. “We’re offering not just compliance but an entirely new level of precision and control in plant production,” Cirillo adds. “For regulated markets, where consistency and quality are critical, this is the kind of solution that can make a real impact.” CAPSERO AG: Best Digital Agriculture Platform in Switzerland 2025 In a momentous achievement, CAPSERO AG has been awarded the title of Best Digital Agriculture Platform in Switzerland for 2025 . Recognized by the prestigious Evergreen Awards, this honor underscores the company’s dedication to sustainability, compliance, and digital innovation in the agricultural sector. CAPSERO’s platform has redefined industry standards for plant-based ingredient production, setting a new benchmark for pharmaceutical, cosmetic, and nutraceutical industries. “We are incredibly proud to receive this recognition,” says Cirillo. “It validates our commitment to pushing the boundaries of what’s possible in plant-based ingredient production. This award reflects the hard work and innovative spirit of the entire CAPSERO team and our supporters.” Global Impact and Market Validation CAPSERO’s innovation is gaining traction in the market. With over 1,300 production unit pre-reservations, the demand for its technology is clear. CAPSERO has also received support from institutions such as INNOSUISSE and the Solar Impulse Foundation, and has earned recognition from Google for Startups. The company’s core technology has been published through the World Intellectual Property Organization (WIPO), further validating its potential. This recognition, paired with Series A funding, positions CAPSERO as an industry leader in AgTech and a driving force for the future of sustainable, compliant plant production. “We are not just responding to market trends; we are shaping them,” Cirillo emphasizes. The Future of Plant-Based Ingredient Production As regulatory pressures mount and environmental concerns continue to grow, the future of plant-based ingredient production hinges on sustainable, compliant solutions. CAPSERO’s technology offers a scalable, automated, and compliant alternative to traditional open-field farming, poised to redefine the future of plant-based raw material production. By enabling the production of high-quality, standardized raw materials that meet stringent regulatory requirements, CAPSERO is uniquely positioned to lead this transformation. As industries continue to prioritize sustainability and compliance, CAPSERO’s innovative platform is more relevant than ever. About CAPSERO AG CAPSERO AG is a Swiss AgTech company revolutionizing plant-based ingredient production. Its patented, fully automated in-vitro cultivation system enables pharmaceutical, cosmetic, and nutraceutical companies to produce high-quality plant-based raw materials under strict GMP, GACP, and ISO-compliant conditions. Backed by institutional and private investors, CAPSERO has received recognition from INNOSUISSE, the Solar Impulse Foundation, and Google for Startups. Media Contact Benjamin Rutz CMO, CAPSERO AG Email: [email protected] Website LinkedIn Instagram Facebook
- August 8, 2025Medicine & Pharmaceuticals
MDC Associates Strengthens Microbiology IVD Support in Response to Shifting Global Standards
MDC Associates, a leading provider of regulatory, clinical, and quality consulting services for diagnostic developers, has announced an expansion of its expertise and support in microbiology IVD (in vitro diagnostics) to meet evolving global regulatory standards. This move reflects growing complexity in the regulatory landscape and heightened expectations for safety, efficacy, and compliance in microbiology diagnostics—a critical segment of healthcare innovation and public health management. Microbiology IVDs play a vital role in detecting, identifying, and managing infectious agents, directly impacting patient outcomes and disease control worldwide. Developers in this space face increasing challenges as regulatory authorities across regions strengthen requirements, particularly under frameworks such as the European Union’s In Vitro Diagnostic Regulation (IVDR) and the US Food and Drug Administration’s (FDA) evolving guidelines. MDC Associates is positioned to guide manufacturers through these shifting demands, offering practical, targeted strategies for clinical study design, regulatory submissions, and quality management systems that align with international expectations. One significant aspect of this expanded focus is MDC’s commitment to early-stage regulatory engagement. Diagnostic developers benefit from strategic FDA Q-submissions that clarify regulatory pathways before formal filings, reducing costly delays and uncertainties. MDC’s team brings a deep understanding of clinical trial design tailored for microbiology diagnostics, ensuring that studies not only meet regulatory benchmarks but also provide robust, clinically meaningful data to support device clearance and reimbursement efforts. The company’s approach emphasizes clarity and transparency, stripping away unnecessary jargon and focusing on actionable steps. Whether assisting with pre-submission planning, designing performance evaluation protocols, or managing technical documentation, MDC ensures clients understand what to expect at every stage. This is particularly crucial as microbiology IVDs often involve complex analytical methods and require evidence that supports safety and accuracy across diverse patient populations and sample types. MDC Associates also assists clients in navigating the quality system requirements mandated by global regulators. Compliance with ISO 13485:2016, integration of risk management principles from ISO 14971, and preparation for audits under both FDA and European frameworks are part of the company’s core competencies. These quality elements are essential for microbiology IVD manufacturers to maintain product integrity and market access, particularly as regulators increase scrutiny on post-market surveillance and adverse event reporting. Beyond regulatory and quality consulting, MDC offers guidance on clinical and performance evaluation studies. With microbiology diagnostics often pivotal in outbreak detection and antimicrobial resistance surveillance, study designs must be rigorous and context-appropriate. MDC’s experts work closely with clients to develop protocols that balance scientific validity with regulatory acceptance, ensuring that studies can withstand regulatory and payer review while delivering insights that benefit public health. The company’s global perspective is an asset for microbiology IVD developers seeking to expand into multiple markets. MDC’s consultants are well-versed in harmonizing submissions across jurisdictions, reducing duplication, and expediting time to market. Their experience with diverse regulatory bodies—from FDA and Health Canada to the European Medicines Agency and emerging markets—equips clients to handle the unique demands of each region without sacrificing compliance or speed. This expanded microbiology IVD support also addresses the growing importance of companion diagnostics and multiplex testing platforms. As diagnostics evolve from single-analyte tests to more complex systems, regulatory pathways become more nuanced. MDC helps manufacturers anticipate these challenges by integrating regulatory strategy with clinical evidence planning and quality assurance, supporting innovation without compromising on regulatory rigor. MDC Associates understands the high stakes for diagnostic developers—balancing tight development timelines, funding constraints, and the imperative to deliver safe, effective products. Their hands-on approach means clients receive personalized service tailored to project scope and company size, whether they are startups navigating initial regulatory hurdles or established firms preparing for complex audits or submissions. Clients engaging MDC can expect detailed project roadmaps, realistic timelines, and ongoing risk assessments to inform decision-making. This level of transparency fosters trust and enables teams to anticipate bottlenecks before they arise, optimizing resource allocation and reducing the risk of unexpected regulatory setbacks. As the microbiology IVD field continues to evolve, MDC Associates remains committed to being a reliable partner for developers at every stage—from concept through commercialization and beyond. By combining technical expertise with practical experience, the company supports clients in meeting regulatory requirements while advancing innovations that enhance patient care and public health outcomes. Developers interested in learning more about MDC Associates’ microbiology IVD consulting services or exploring how regulatory strategies can be optimized for current and future market challenges are encouraged to schedule a consultation or download the company’s clinical study planning checklist. This resource offers a detailed framework for aligning clinical trial design with regulatory expectations, helping developers move confidently through the complex landscape of microbiology diagnostics. MDC Associates continues to build on decades of experience to help diagnostic developers worldwide navigate an increasingly demanding regulatory environment, ensuring that innovations reach patients safely and efficiently. The company’s expanded microbiology IVD services underscore its commitment to delivering clear, actionable guidance that supports compliance, quality, and clinical success in one of the most critical areas of in vitro diagnostics. About MDC Associates: MDC provides life-saving diagnostic makers with the right support and catered solutions needed to make our world a healthier place. With over 35 years of experience, MDC Associates has the experience and expertise to provide unparalleled regulatory strategy and execution, full-service CRO planning and study management, quality systems design and implementation, and data management support, guidance, and analysis. Located on the technology corridor north of Boston, Massachusetts, MDC has earned a reputation of trust with companies of all sizes that develop, manufacture, and distribute in vitro diagnostic tests and instruments. The unique way MDC focuses its work and counsel guides clients in demonstrating safety and efficacy to achieve product approval, making MDC a valuable partner on the path to commercial success.
- August 6, 2025Medicine & Pharmaceuticals
Director Chris Dela Cruz Announces Premiere of ‘Tiny Hearts’ Documentary on Pediatric Heart Surgery
Filmmaker Chris Dela Cruz has announced the world premiere of Tiny Hearts , a feature-length documentary chronicling pediatric heart surgeon Dr. William Novick and the Global Cardiac Alliance as they respond to urgent medical needs in conflict-affected countries. Filmed over five years in seven nations—including Lebanon, Iraq, Ukraine, and the Democratic Republic of Congo—the documentary provides direct access to life-saving surgeries for children born with congenital heart defects in regions facing war, instability, and resource scarcity. Photo Courtesy of: Chris Robbins/Jordan Campbell The film captures front-line medical missions as Novick’s team confronts challenging conditions, frequent shortages, and unrelenting chaos. “We go where the need is,” Dr. Novick said. “That’s the only compass that matters.” Tiny Hearts forgoes dramatization to show the realities of surgery in overstretched hospitals, highlighting the logistics, teamwork, and determination required for each operation. Dela Cruz, who is a Writers Guild of America member and former video editor, also contributed financially, along with other financial contributors. He gained unprecedented access to the stories unfolding inside war zone hospitals. “I didn’t want to just observe—I wanted to immerse myself,” said Dela Cruz. “That meant being in the ICU, breathing the same air, feeling the urgency of every heartbeat. The emotional weight of it. The moral gravity.” He added, “This isn’t just a documentary. It’s a call to action. These children are real. Their stories matter. And if this film helps save even one more life, then everything I gave up was worth it.” The documentary also features original music by Grammy Award-winning producer Philip Lawrence, with additional contributions from Christina Perri and a score by Edmund Butt and Benjamin Wallfisch. Michael Lehmann Boddicker oversaw audio post-production. Tiny Hearts is scheduled for premiere at major film festivals in 2025. About Tiny Hearts Tiny Hearts is a feature-length documentary directed by Chris Dela Cruz that brings audiences into the challenging world of pediatric heart surgery in conflict and crisis regions. Filmed over five years in seven countries—including Lebanon, Iraq, Ukraine, and the Democratic Republic of Congo—the film documents the work of Dr. William Novick and the Global Cardiac Alliance as they perform surgeries for children with congenital heart defects. With unprecedented access to medical teams, patients, and families, Tiny Hearts provides a clear look at the realities faced in resource-limited hospitals and the impact of humanitarian intervention. The film’s original score and contributions from award-winning musicians further enhance its powerful storytelling. Tiny Hearts aims to raise global awareness about pediatric healthcare inequalities in war-torn areas.
- August 1, 2025Medicine & Pharmaceuticals
Cannabis Products Lack Safety Labels, Use Kid-Friendly Packaging, Study Finds
A new study published in the American Journal of Preventive Medicine reveals that cannabis products sold in unlicensed retail shops often lack essential health and safety labels, and many feature colorful, cartoon-like packaging designed to attract children. The analysis compared 88 cannabis products from licensed and unlicensed New York City retailers and uncovered striking differences. Only about 1 in 30 of unlicensed cannabis products carried all six of New York State’s required health warnings and safety features, compared to roughly half of licensed products. Most unlicensed products did not list their THC potency, and nearly all provided no dosage guidance. “This study reveals a serious gap in regulation that puts consumers at risk,” said Dr. Ryan Sultan, a Columbia University child psychiatrist and co-author of the study, “We need coordinated action at both the state and federal levels to ensure cannabis product safety and to rein in misleading packaging.” By contrast, all licensed products in the sample disclosed THC content and about half included a standard dose indication. Many unlicensed packages even displayed official-looking symbols from other states, for example, California’s universal cannabis symbol, or included warnings about delayed effects meant for edibles, even when the product was not an edible. The researchers note that such mislabeling could give consumers a false sense of security about unregulated products. “Misleading or incomplete labels can lead to real harm, because consumers may not know what they’re actually getting,” said Dr. Tim Becker, Cornell psychiatrist and the study’s lead author. “It’s especially troubling to see how many products were clearly designed to catch the eye of kids or teens –that’s a public health concern we can’t ignore.” Another key finding was the prevalence of youth-oriented branding on cannabis packaging. Nearly all of products examined had elements likely to appeal to minors, such as bright, multicolored designs, playful fonts, or cartoon imagery. This trend was even more pronounced in unlicensed items: about 1 in 4 of unlicensed packages featured cartoon characters or graphics, versus 0% of licensed products. In New York, regulations prohibit marketing to minors, making these findings especially alarming. Cannabis use for minors has been associated with depression , ADHD , and anxiety . About Integrative Psychiatry is a mental health practice led by Dr. Ryan Sultan. The clinic provides comprehensive psychiatric and therapeutic services for children, adolescents, and adults, utilizing a holistic, evidence-based approach tailored to each individual’s unique needs. From ADHD , anxiety , and depression treatment to OCD , addiction , and trauma therapy, Integrative Psych’s multidisciplinary team provides personalized care to help clients achieve long-term well-being. Social Links LinkedIn Media Contact Full Name: Ryan Sultan Title: Integrative Psychiatrist Company Name: Integrative Psychiatry of Manhattan Website: https://www.integrative-psych.org
- July 29, 2025Medicine & Pharmaceuticals
HEALTHandMED Highlights Whole Body Vibration System in Commitment to Noninvasive Wellness
Since 2007, HEALTHandMED has upheld its reputation as a reliable source of natural health solutions, delivering noninvasive tools that support individual wellness journeys. Staying aligned with its commitment to innovative health equipment, the company offers the GForce Pro – 1500W Dual Motor Whole Body Vibration Exercise Machine as part of its range of vibration exercise equipment . HEALTHandMED’s catalog includes a wide array of natural health technologies such as infrared saunas, ionic foot detox systems, photobiomodulation beds, nutritional supplements, and vibration therapy machines. Each product is designed to help users explore wellness outside conventional clinical models. “The GForce Pro represents our ongoing mission to provide individuals with effective, user-friendly options that promote physical well-being without invasive methods,” said a spokesperson for HEALTHandMED. “For many, vibrating exercise equipment has become a valuable component of their daily wellness routine.” The GForce Pro system operates with a 1500W dual motor and features whole-body vibration capabilities designed to support users seeking supplemental physical stimulation. It is widely utilized by individuals interested in muscle activation, circulation support, and flexibility enhancement in the comfort of their home environment. While vibration therapy has gained attention across wellness communities, HEALTHandMED emphasizes that its equipment is not a substitute for medical treatment. “Customer experiences often speak to increased energy and physical resilience,” the spokesperson added. Nevertheless, we highly recommend that individuals consult their healthcare provider before beginning any exercise program, including vibration therapy. Note: While many customers have reported noticeable benefits, these statements have not been evaluated by the FDA. The GForce Pro Vibration Machine is not designed to diagnose, treat, cure, or prevent any medical condition. HEALTHandMED is committed to providing resources that enable individuals to make knowledgeable choices about their health. Through consistent product research, customer service, and support, the company aims to remain a valuable partner in the broader wellness landscape.
- July 29, 2025Medicine & Pharmaceuticals
HEALTHandMED Adds IonizeMe Machines to Its Product Range
HEALTHandMED, a leader in the health and wellness equipment market, announces the addition of IonizeMe machines and a variety of ionic foot detox accessories to its product offerings. The company is committed to supplying customers with tools that enhance wellness routines using advanced technology designed to support overall health and well-being. A spokesperson from HEALTHandMED stated, “We are pleased to provide detox machines for feet to our customers.” HEALTHandMED’s product line includes the IonizeMe machines, which are manufactured domestically in the United States. These machines are developed to enable users to undergo ionic foot detoxification. The company explains that the IonizeMe machine functions by using ionization technology to promote cleansing through the feet, supporting the body’s natural detoxification mechanisms. The firm emphasizes that the IonizeMe machines come with a full five-year warranty. Each purchase also includes a complimentary consultation with a qualified physician. Alongside the IonizeMe machines, HEALTHandMED offers a comprehensive selection of ionic foot detox accessories designed to enhance the detoxification process. These accessories allow customers to tailor their experience for optimal results. The company representative added, “By providing high-quality products along with professional consultations, HEALTHandMED continues to uphold its reputation for delivering dependable health solutions. IonizeMe machines are among the most powerful and effective ionic detox devices available, producing a high volume of ions.” With the inclusion of IonizeMe machines and associated accessories, HEALTHandMED has strengthened its standing as a trustworthy and credible health equipment provider. Disclaimer: These statements have not been evaluated by the FDA. The Ionic Detox System is not intended to diagnose, treat, cure, or prevent any disease.
- July 29, 2025Medicine & Pharmaceuticals
HEALTHandMED Highlights GForce Pro Total Body Vibration Machine for Whole-Body Wellness
HEALTHandMED, a leading provider of natural wellness technology, continues to spotlight the enduring value of its GForce Pro 1500W Dual Motor Whole Body Vibration Exercise Machine. Designed for individuals seeking non-invasive support for circulation, strength, balance, and recovery, the total body vibration machine represents a cornerstone in passive fitness and therapeutic health equipment. "The GForce Pro continues to earn high praise because it combines versatility, power, and science-backed benefits," said a spokesperson from HEALTHandMED. "Whether it's improving bone density, stimulating muscle engagement, or reducing inflammation, this platform allows users to engage in effective, low-impact exercise on their own schedule." The GForce Pro features dual 1500W motors engineered for Oscillation/Pivotal and Triplanar movement—two vibration modes scientifically recognized for promoting distinct wellness outcomes. Oscillation motion enhances lymphatic drainage, balance, and rapid muscle activation, while Triplanar motion focuses on building muscle strength, increasing bone density, and reducing joint stiffness. Together, they deliver a comprehensive vibration experience that addresses a wide range of needs. This model offers 60 speed settings per motor and nine workout modes, including manual, automatic, and user-defined programs. The large 27" x 20" platform accommodates various postures and exercise styles, and arm straps are included for upper body engagement. Users receive an exercise chart with 26 targeted exercises to maximize results. From professional athletes to aging adults seeking improved mobility, the GForce Pro is a powerful solution for long-term physical maintenance. With its steel body construction, noiseless motors, and enhanced digital control panel, the GForce Pro is built for frequent use in both home and professional environments. This makes it particularly well-suited for rehabilitation clinics, physical therapy offices, fitness centers, and high-use households. HEALTHandMED remains committed to making accessible, science-aligned wellness products for proactive health management. Backed by customer support, U.S.-based warranty services, and education resources, the company continues to help users take ownership of their well-being.
- July 29, 2025Medicine & Pharmaceuticals
HEALTHandMED Highlights the GForce Pro 1500W Dual Motor Whole Body Vibration Machine for High-Performance Wellness
HEALTHandMED is spotlighting its GForce Pro 1500W Dual Motor Whole Body Vibration Exercise Machine as a long-trusted wellness solution engineered for passive fitness and full-body conditioning. The platform is designed for high-demand users—from physical therapy centers and senior facilities to health-conscious individuals seeking reliable, results-driven equipment. "Many platforms focus on gimmicks, but we built the GForce Pro to deliver consistent outcomes in real-world use," said a spokesperson for HEALTHandMED. "Whether for rehab patients, active seniors, or busy clinics, this system offers measurable functionality—not just convenience." Built for resilience, the GForce Pro leads the market in whole-body vibration machine comparisons with a heavy-duty steel frame, large 27" x 20" plate, and dual motor design. Oscillation, also known as pivotal vibration, supports balance, lymphatic drainage, and reflex stimulation. In contrast, tri-planar vertical vibration helps engage deeper muscles, supporting bone health, strength, and muscle tone. Together, these vibration modes offer 60 adjustable speed levels and nine workout programs, including user-defined custom settings. This flexibility enables users to tailor sessions for relaxation, rehab, or muscle activation without stressing joints. Included arm bands enhance upper-body engagement, while the platform supports up to 400 lbs—ideal for clinics and high-use environments. A full exercise chart comes standard with the machine, covering 26 structured activities from stretching and strength-building to core work. This, along with online training resources, allows users to create a balanced wellness routine without the need for a full gym setup. With upgraded noiseless motors, simplified digital controls, and advanced programming modes, the GForce Pro is trusted by users looking for function, durability, and adaptability. Its dual-motion design enables users to alternate between recovery-based sessions and more intense conditioning protocols, all within a single unit.
ALL NEWS
- TNT Paving & Excavating Helps Sonora Residents Prevent Flooding with Expert Excavation and Drainage Services
- Lakeland, WA Orthodontic Aligners & Discreet Teeth Straightening: Options Expand
- Federal Way Invisalign & SureSmile Clear Braces, Orthodontic Treatments Update
- Algona Pediatric Orthodontic Practice: Invisalign For Bite Issues Available
- Colfax Pizza Catering & Large Orders for Church Events, Youth Groups Announced
- Mats4U Expands Custom Logo Mats with 100 New Color Choices for Enhanced Branding Solutions
- Pleasanton Functional Lab & Food Sensitivity Testing Services Announced
- Hype Luxury Announces Expansion into the US Market and Redefines Global Luxury Mobility
- Matrixport's Cactus Custody and OnChain Tokenize CMB International's USD Fund on Blockchain
- The Digital Marketing Agency & Consulting Company LLC Opens East Bay Office in Union City
- God Bless Retirement Named Best M&A Advisory Firm in Fort Worth for 2025, Expands Comprehensive Services for Business Buyers and Sellers
- Britney Hairland Announces Global Expansion and New Hair Extensions Production Facility in Croatia
- Generation AI: Tony Evans Unveils New Book to Help Leaders Navigate AI in the Workplace
- Chowbus Unveils $1M Tech Investment to Fuel Restaurant Growth
- Xraised Honors Kathryn Lancioni
- Netty Awards Spotlight Top Digital Agencies in Los Angeles
- AnnaSpanish Offers New Clients 1:1 Spanish Tuition Online, Delivering Flexibility & Convenience For Busy Professionals
- Glacier Haven Resort Enhances Guest Experience with Upgraded RV and Cabin Accommodations
COMMUNICATE. COMMAND. COMMERCE.
Lead the conversation of your brand & win more customers with MarketersMEDIA Solutions.
Explore Now